Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-04-18 4:15 pm Purchase | 2022-04-14 | 13G | INOZYME PHARMA INC INZY | Deep Track Capital, LP | 3,250,000 8.110% | 3,250,000 (New Position) | Filing History |
| 2022-04-08 4:34 pm Purchase | 2022-03-31 | 13G | AGENUS INC AGEN | Deep Track Capital, LP | 775,927 5.920% | 775,927 (New Position) | Filing History |
| 2022-03-04 4:10 pm Purchase | 2022-03-02 | 13G | HOOKIPA PHARMA INC HOOK | Deep Track Capital, LP | 503,600 9.900% | 503,600 (New Position) | Filing History |
| 2022-02-18 4:11 pm Purchase | 2022-02-17 | 13G | NKARTA INC NKTX | Deep Track Capital, LP | 1,965,684 5.970% | 1,965,684 (New Position) | Filing History |
| 2022-02-16 4:46 pm Purchase | 2022-02-14 | 13G | CHINOOK THERAPEUTICS INC KDNY | Deep Track Capital, LP | 2,752,070 5.040% | 2,752,070 (New Position) | Filing History |
| 2022-02-14 09:08 am Purchase | 2021-12-31 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Deep Track Capital, LP | 1,900,000 4.000% | 1,334 (+0.07%) | Filing History |
| 2022-02-14 09:01 am Sale | 2021-12-31 | 13G | TRAVERE THERAPEUTICS INC TVTX | Deep Track Capital, LP | 2,450,000 4.000% | -640,200 (-20.72%) | Filing History |
| 2022-02-14 09:00 am Sale | 2021-12-31 | 13G | AVROBIO INC AVRO | Deep Track Capital, LP | 87,511 2.410% | -96,750 (-52.51%) | Filing History |
| 2022-02-14 09:00 am Sale | 2021-12-31 | 13G | REPARE THERAPEUTICS INC RPTX | Deep Track Capital, LP | 2,100,000 5.030% | -4,600 (-0.22%) | Filing History |
| 2022-02-14 08:59 am Purchase | 2021-12-31 | 13G | PASSAGE BIO INC PASG | Deep Track Capital, LP | 160,850 5.950% | 18,203 (+12.76%) | Filing History |
| 2022-02-14 08:58 am Purchase | 2021-12-31 | 13G | MAGENTA THERAPEUTICS INC MGTA | Deep Track Capital, LP | 4,870,000 8.290% | 714,445 (+17.19%) | Filing History |
| 2022-02-14 08:58 am Purchase | 2021-12-31 | 13G | KEROS THERAPEUTICS INC KROS | Deep Track Capital, LP | 1,300,000 5.500% | 11,276 (+0.87%) | Filing History |
| 2022-02-14 08:57 am Purchase | 2021-12-31 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Deep Track Capital, LP | 1,500,000 6.130% | 233,116 (+18.40%) | Filing History |
| 2022-02-14 08:56 am Purchase | 2021-12-31 | 13G | JOUNCE THERAPEUTICS INC. JNCE | Deep Track Capital, LP | 4,000,000 7.810% | 143,537 (+3.72%) | Filing History |
| 2022-02-14 08:56 am Purchase | 2021-12-31 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | Deep Track Capital, LP | 1,900,000 5.910% | 100,000 (+5.56%) | Filing History |
| 2022-02-14 08:55 am Purchase | 2021-12-31 | 13G | ASSEMBLY BIOSCIENCES INC ASMB | Deep Track Capital, LP | 250,000 6.270% | 50,510 (+25.32%) | Filing History |
| 2022-02-11 5:11 pm Purchase | 2022-02-04 | 13G | IMMUNOVANT INC IMVT | Deep Track Capital, LP | 6,780,827 5.830% | 6,780,827 (New Position) | Filing History |
| 2022-02-03 9:43 pm Purchase | 2022-01-28 | 13G | KURA ONCOLOGY INC KURA | Deep Track Capital, LP | 3,362,000 5.050% | 3,362,000 (New Position) | Filing History |
| 2022-01-27 4:35 pm Purchase | 2022-01-24 | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | Deep Track Capital, LP | 1,496,138 5.090% | 1,496,138 (New Position) | Filing History |
| 2022-01-27 4:34 pm Purchase | 2022-01-24 | 13G | ACUMEN PHARMACEUTICALS INC ABOS | Deep Track Capital, LP | 2,414,917 5.970% | 2,414,917 (New Position) | Filing History |